Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06747351

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Led by Takeda · Updated on 2026-01-20

59

Participants Needed

52

Research Sites

163 weeks

Total Duration

On this page

Sponsors

T

Takeda

Lead Sponsor

T

Takeda Development Center Americas, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main aim of this study is to evaluate the pharmacokinetic (PK) comparability between TAK-881 and HYQVIA subcutaneous (SC) administration for maintenance therapy of CIDP. The participants who are already receiving intravenous immunoglobulin G (IGIV), conventional subcutaneous intravenous immunoglobulin G (cIGSC), or HYQVIA will be treated with the same dose equivalent as their prior IG treatment with HYQVIA for 20 weeks followed by TAK-881 for 24 weeks. Participants will need to visit the clinic every 3 or 4 weeks until they enter the extension phase. In the extension phase, home infusions are allowed, and visits will occur between every 12 weeks and 24 weeks.

CONDITIONS

Official Title

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to comply with trial procedures
  • Provided written informed consent
  • Documented diagnosis of CIDP or possible CIDP per EFNS/PNS 2021 criteria by a neuromuscular specialist
  • Previously responded to IgG treatment with partial or complete symptom resolution
  • On stable IGIV, cIGSC, or HYQVIA treatment with monthly IgG dose 0.4 to 2.4 g/kg for at least 12 weeks before screening
  • IGIV dosing interval between 2 and 6 weeks; cIGSC dosing weekly or biweekly; HYQVIA dosing up to 6 weeks
  • INCAT disability score between 0 and 7 inclusive, meeting specified scoring conditions
  • Negative pregnancy test if potential to become pregnant and agreement to use effective contraception during and 30 days after treatment
Not Eligible

You will not qualify if you...

  • Diagnosis of focal, multifocal, distal, or sensory CIDP or possible forms per EFNS/PNS 2021
  • Neuropathy from other causes including hereditary neuropathies, infections, systemic diseases, MMN, or toxin-induced neuropathy
  • Chronic or debilitating diseases affecting neurological assessment (e.g., multiple sclerosis, stroke, Parkinson's disease)
  • Use of immunomodulatory/immunosuppressive agents other than IGIV, cIGSC, or fIGSC within 6 months
  • Long-term corticosteroid use >20 mg/day prednisone-equivalent for >30 days within 3 months
  • Plasma exchange within 3 months before screening
  • IgM paraproteinemia or IgA deficiency with hypersensitivity to immunoglobulin treatment
  • Conditions altering protein catabolism or IgG use (e.g., nephrotic syndrome)
  • Chronic kidney disease with GFR <30 mL/min/1.73 m2
  • Malignancy with less than 2 years remission or active cancer requiring treatment
  • Severe heart conditions or uncontrolled hypertension
  • Thrombophilic disorders or recent thromboembolic events
  • Hypersensitivity to IGIV, IGSC, TAK-881, HYQVIA, hyaluronidase, or related excipients
  • Positive for hepatitis B surface antigen, HIV, or active hepatitis C infection
  • Clinically significant anemia or certain abnormal lab values
  • Pregnant or lactating women
  • Participation in another investigational trial within 12 weeks or 5 half-lives
  • Trial site employees or immediate family members involved in this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 52 locations

1

HonorHealth Neurology

Scottsdale, Arizona, United States, 85251

Actively Recruiting

2

Stanford Neuroscience Health Center

Palo Alto, California, United States, 94304

Not Yet Recruiting

3

Yale University School of Medicine

New Haven, Connecticut, United States, 06510

Not Yet Recruiting

4

Neurology Associates

Maitland, Florida, United States, 32751

Actively Recruiting

5

Knight Neurology

Rockledge, Florida, United States, 32955

Actively Recruiting

6

The Washington University

St Louis, Missouri, United States, 63130

Not Yet Recruiting

7

NYU Langone Health

New York, New York, United States, 10016

Actively Recruiting

8

University of North Carolina (UNC)

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

9

Duke University Hospital

Durham, North Carolina, United States, 27710

Actively Recruiting

10

Raleigh Neurology Associates

Raleigh, North Carolina, United States, 27607

Actively Recruiting

11

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States, 27157

Actively Recruiting

12

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Not Yet Recruiting

13

Oregon Health & Science University (OHSU) - Nephrology and Hypertension Clinic - Marquam Hill

Portland, Oregon, United States, 97239

Not Yet Recruiting

14

Neurology Rare Disease Center

Denton, Texas, United States, 76208

Actively Recruiting

15

The University of Vermont Medical Center

Burlington, Vermont, United States, 05401

Not Yet Recruiting

16

BCN Research, LLC

Greenfield, Wisconsin, United States, 53228

Actively Recruiting

17

INECO

Rosario, Santa Fe Province, Argentina, 2000

Not Yet Recruiting

18

Instituto Argentino de Investigacion Neurologica (IADIN)

Buenos Aires, Argentina, C1015ABR

Not Yet Recruiting

19

Fakultni nemocnice Hradec Kralove

Hradec Králové, Czechia, 500 05

Not Yet Recruiting

20

Copenhagen University Hospital

Copenhagen, Capital Region, Denmark, 2100d

Not Yet Recruiting

21

Aarhus Universitetshospital

Aarhus, Central Jutland, Denmark, 8200

Actively Recruiting

22

Universitätsklinikum Mannheim GmbH

Mannheim, Baden-Wurttemberg, Germany, 68167

Not Yet Recruiting

23

University of Ulm

Ulm, Baden-Wurttemberg, Germany, 89081

Not Yet Recruiting

24

Universitaetsklinikum Giessen und Marburg GmbH Standort Marburg

Marburg, Hesse, Germany, 35043

Not Yet Recruiting

25

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany, 30625

Not Yet Recruiting

26

Charite - Universitatsmedizin Berlin

Berlin, Germany, 12203

Not Yet Recruiting

27

Attikon University General Hospital

Athens, Attica, Greece, 12462

Not Yet Recruiting

28

University General Hospital of Patras

Patras, Peloponnese, Greece, 26504

Not Yet Recruiting

29

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele

Milan, Lombardy, Italy, 20132

Not Yet Recruiting

30

IRCCS Istituto Clinico Humanitas

Rozzano, Milano, Lombardia, Italy, 20089

Not Yet Recruiting

31

Azienda Ospedaliero - Universitaria San Luigi Gonzaga

Orbassano, Torino, Piemonte, Italy, 10043

Not Yet Recruiting

32

ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia

Brescia, Italy, 25123

Not Yet Recruiting

33

Ospedale San Martino

Genova, Italy, 16132

Not Yet Recruiting

34

Az Ospedaliera Universitaria Policlinico G Martino

Messina, Italy, 98125

Not Yet Recruiting

35

Fondazione Istituto Neurologico Casimiro Mondino

Pavia, Italy, 27100

Not Yet Recruiting

36

Azienda Ospedaliero Universitaria Pisana

Pisa, Italy, 56126

Not Yet Recruiting

37

Azienda Ospedaliera Universitaria Policlinico Tor Vergata

Rome, Italy, 00133

Not Yet Recruiting

38

Japan Organization of Occupational Health and Safety Chubu Rosai Hospital

Nagoya, Aichi-ken, Japan, 455-8530

Not Yet Recruiting

39

Kumamoto University Hospital

Kumamoto, Kumamoto, Japan, 860-8556

Actively Recruiting

40

Tohoku Medical and Pharmaceutical University Hospital

Sendai, Miyagi, Japan, 981-8558

Not Yet Recruiting

41

Nara Medical University Hospital

Kashihara, Nara, Japan, 634-8522

Not Yet Recruiting

42

Higashimatsuyama Municipal Hospital

Higashi-Matsuyama, Saitama, Japan, 355-0005

Actively Recruiting

43

Shiga University of Medical Science Hospital

Ōtsu, Shiga, Japan, 520-2192

Not Yet Recruiting

44

Tokushima University Hospital

Tokushima, Tokuchima, Japan, 770-8503

Not Yet Recruiting

45

Juntendo University Hospital

Bunkyo-ku, Tokyo, Japan, 113-8431

Actively Recruiting

46

Oddzial Kliniczny Neurologii

Krakow, Lesser Poland Voivodeship, Poland, 30-688

Not Yet Recruiting

47

Clinirem Sp zo.o.

Lublin, Lublin Voivodeship, Poland, 20-064

Actively Recruiting

48

Warszawski Uniwersytet Medyczny

Warsaw, Masovian Voivodeship, Poland, 02-097

Not Yet Recruiting

49

Copernicus Podmiot Leczniczy

Gdansk, Pomeranian Voivodeship, Poland, 80-462

Not Yet Recruiting

50

Hospital de La Santa Creu I San Pau

Barcelona, Spain, 08041

Not Yet Recruiting

51

Hospital Universitari i Politecnic La Fe

Valencia, Spain, 46026

Not Yet Recruiting

52

Sahlgrenska Universitetssjukhuset

Gothenburg, Västra Götaland County, Sweden, 41345

Actively Recruiting

Loading map...

Research Team

T

Takeda Contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here